期刊文献+

肺腺癌中EGFR19/21基因突变与Ki67、P53蛋白的表达及意义 被引量:6

Expression and significance of EGFR19/21 gene mutations in lung adenocarcinoma and Ki67,P53 protein
下载PDF
导出
摘要 目的探讨肺腺癌组织中EGFR19/21基因突变与Ki67,P53表达的相关性及临床意义。方法回顾性分析140例病理确诊为肺腺癌的患者,均经Taqman-ARMS法检测肿瘤组织EGFR19/21基因突变状况,并根据结果进行分组;应用免疫组化SP方法检测两组肿瘤组织中Ki67、P53蛋白的表达情况,对两组检测结果并结合其临床和病理资料应用SPSS 18.0进行统计学分析。结果 140例肺腺癌病例中Ki67蛋白高表达率为(32/140,22.9%);P53蛋白阳性表达率为(63/140,45%);Ki67高表达与肿瘤大小、有否淋巴结转移、分化程度、P-TNM分期有显著相关(P<0.001),与EGFR基因突变状况无关(P=0.227,P>0.05)。P53表达与肿瘤大小、有否淋巴结转移、P-TNM分期有关(P<0.05),与EGFR基因突变状况有关(P=0.041,P<0.05)。EGFR基因突变与P53表达存在正相关性(r=0.173,P<0.05),与Ki67高表达不存在相关性(r=-0.102,P>0.05);P53和Ki67表达间存在正相关性(r=0.166,P<0.05)。结论EGFR基因突变,Ki67、P53蛋白表达在肺腺癌的发生、侵袭、转移起重要作用,联合检测对肺腺癌患者病理诊断、恶性程度判断、个体化治疗选择及预后评估有重要临床意义。 Objective To research the relationship between EGFR 19/21 gene mutation in lung adenocarcinoma patients and lung cancer associated proteins of Ki 67 and P53 expressions and clinical significance .Methods Retrospective analysis of 140 cases of pathological diagnosed with lung adenocarcinoma patients specimens , the EGFR19/21 gene mutation in the tumor tissue used Taqman-ARMS assay, and divided into two groups according to the results .The expression of Ki67 and P53 proteins in tumor specimens of two groups used immunohistochemical SP method , The results of two groups of testing and the clinical and pathological data using SPSS 18.0 to statistical analysis.Results In the 140 cases of lung adenocarcinoma cases , Ki67 protein high expression rate (32/140,22.9%); P53 protein positive expression rate (63/140, 45%); Ki67 expression were significantly related with the tumor size , lymph node metastasis , differentiation , P-TNM stage (P〈0.001), and no correlated with the EGFR mutation status (P=0.227, P〉0.227).P53 expression were related with the tumor size, lymph node metastasis and P-TNM staging ( P 〈0.05), associated with EGFR mutation situation (P=0.041, P〈0.05).EGFR gene mutation and P53 positive correlation (r=0.173, P〈0.05), EGFR gene mutation and Ki67 doesn&#39;t exist correlation (r=0.102, P〉0.102); Positive correlations between P53 and Ki67 expressions (r =0.166, P 〈0.05).Conclusions The EGFR gene mutation, the expression of Ki67 and P53 proteins played an important role in lung adenocarcinoma carcinogenesis and invasion and metastasis , the joint detection of lung adenocarcinoma patients with pathologic diagnosis , judging malignant degree, individualized treatment choice and prognosis assessment has important clinical significance .
作者 何锋 陈树兴
出处 《齐齐哈尔医学院学报》 2015年第16期2344-2347,共4页 Journal of Qiqihar Medical University
关键词 肺癌 EGFR 基因突变 KI67 P53 EGFR Lung adenocarcinoma EGFR Gene mutation
  • 相关文献

参考文献16

  • 1Burgess DJ. Cancer genetics : Initially complex, always heterogeneous Nat [ J ]. Rev. Cancer,2011,11 : 153.
  • 2Bunnell CA, Shulman LN. Will we be able to care for cancer patients in the future? [ J ]. Oncology ( Williston Park ), 2010, 14 : 1343-1348.
  • 3许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1366
  • 4Lynch TJ,Bel DW, Sordela R, et al. Activething mutations in the epidermal growthfactor receptor underthing responsiveness of non- small-cell lung cancer to gefitinib [ J ]. N E J Med, 2004,350 (21) :2129.
  • 5Petrelli F, Borgonovo K, Cabiddu M, et al. Efficacy of EGFR tyrosin kinase inhibitors in patients with EGFR-mutated non-small- cell lung cancer. A meta-analysis of 13 randomized trials [ J ]. Clin. Lung Cancer,2012,13 : 107-114.
  • 6Ji H, Zhao X, Yuza Y, et al. Epidermal growth factor receptor variant In mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors[ J ]. Proc Natl Acad Sci USA, 2006,103:7817- 7822.
  • 7Petrelli F, Borgonovo K, Cabiddu M, et al. Efficacy of EGFR tyrosin kinase inhibitors in patients with EGFR-mutated non-small- cell lung cancer. A meta-analysis of 13 randomized trials [ J ].Clin. Lung Cancer,2012,13 : 107-114.
  • 8Gentile V, Vicini P, Giacomelli L, et al. Detection of human papillomavirus DNA, p53 and Ki67 expression in penile earcinomas [J]. Int J Immunopathol Pharmacol,2006,19( 1 ) :209-215.
  • 9杨映红,林明稀,郑宇辉,黄建平,杨发端.分化抑制蛋白Id1和PCNA及Ki67在肝细胞癌中的表达及意义[J].中国肿瘤临床与康复,2008,15(1):30-32. 被引量:8
  • 10何振宇,李彪,胡英,管迅行.Ki67在乳腺癌组织中的表达及临床病理分析[J].中国初级卫生保健,2005,19(12):94-95. 被引量:16

二级参考文献45

共引文献1413

同被引文献32

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部